[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588709":3},{"organization":4,"armGroups":7,"interventions":65,"overallOfficials":76,"centralContacts":81,"locations":86,"responsibleParty":300,"collaborators":71,"id":302,"slug":303,"hasResults":304,"nctId":305,"briefTitle":306,"officialTitle":307,"acronym":71,"eligibilityCriteria":308,"healthyVolunteers":309,"sex":310,"minAge":311,"maxAge":312,"enrollmentInfo":313,"targetDuration":71,"studyType":316,"phases":317,"briefSummary":319,"conditions":320,"keywords":71,"overallStatus":89,"whyStopped":71,"lastUpdateSubmitDate":322,"lastUpdatePostDateStruct":323,"startDateStruct":326,"completionDateStruct":328,"leadSponsor":330,"locationsCount":331},{"fullName":5,"class":6},"Bambusa Therapeutics","INDUSTRY",[8,14,18,22,28,32,36,40,44,47,50,54,58,62],{"label":9,"type":10,"description":11,"interventionNames":12},"Part A: BBT002","EXPERIMENTAL","A single dose of BBT002 will be administered in healthy volunteers",[13],"Drug: BBT002",{"label":15,"type":10,"description":16,"interventionNames":17},"Part B: BBT002","Multiple doses of BBT002 will be administered in healthy volunteers.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Part C: BBT002","Multiple doses of BBT002 will be administered in patients with COPD",[13],{"label":23,"type":24,"description":25,"interventionNames":26},"Part A: Placebo","PLACEBO_COMPARATOR","A single dose of Placebo will be administered in healthy volunteers.",[27],"Drug: Placebo",{"label":29,"type":24,"description":30,"interventionNames":31},"Part B: Placebo","Multiple doses of Placebo will be administered in healthy volunteers.",[27],{"label":33,"type":24,"description":34,"interventionNames":35},"Part C: Placebo","Multiple doses of Placebo will be administered in patients with COPD.",[27],{"label":37,"type":24,"description":38,"interventionNames":39},"Part D: Placebo","Multiple doses of Placebo will be administered in patients with CRSwNP.",[27],{"label":41,"type":24,"description":42,"interventionNames":43},"Part E: Placebo","Single dose of Placebo will be administered in healthy volunteers.",[27],{"label":45,"type":24,"description":34,"interventionNames":46},"Part F: Placebo",[27],{"label":48,"type":24,"description":38,"interventionNames":49},"Part G: Placebo",[27],{"label":51,"type":10,"description":52,"interventionNames":53},"Part D: BBT002","Multiple doses of BBT002 will be administered in patients with CRSwNP.",[13],{"label":55,"type":10,"description":56,"interventionNames":57},"Part E: BBT002","Single dose of BBT002 will be administered in healthy volunteers.",[13],{"label":59,"type":10,"description":60,"interventionNames":61},"Part F: BBT002","Multiple doses of BBT002 will be administered in patients with COPD.",[13],{"label":63,"type":10,"description":52,"interventionNames":64},"Part G: BBT002",[13],[66,72],{"type":67,"name":68,"description":69,"armGroupLabels":70,"otherNames":71},"DRUG","BBT002","BBT002 will be administered.",[9,15,19,51,55,59,63],null,{"type":67,"name":73,"description":74,"armGroupLabels":75,"otherNames":71},"Placebo","Placebo will be administered.",[23,29,33,37,41,45,48],[77],{"name":78,"affiliation":79,"role":80},"Tracy Ji","Bambusa Therapeutics, Inc.","STUDY_DIRECTOR",[82],{"name":78,"role":83,"phone":84,"phoneExt":71,"email":85},"CONTACT","+86 18001322760","Tracy.Ji@bambusatx.com",[87,108,125,139,156,171,188,200,210,222,240,254,268,285],{"facility":88,"status":89,"city":90,"state":91,"zip":92,"country":93,"countryCode":94,"cosmosGeoPoint":95,"geoPoint":100,"contacts":101},"Equity Medical Bowling Green","RECRUITING","Bowling Green","Kentucky","42104","United States","US",{"type":96,"coordinates":97},"Point",[98,99],-86.4436,36.99032,{"lat":99,"lon":98},[102,106],{"name":103,"role":83,"phone":104,"phoneExt":71,"email":105},"Dr. James Allred","844-378-9633","Jallred@equity-med.com",{"name":103,"role":107,"phone":71,"phoneExt":71,"email":71},"PRINCIPAL_INVESTIGATOR",{"facility":109,"status":110,"city":111,"state":91,"zip":112,"country":93,"countryCode":94,"cosmosGeoPoint":113,"geoPoint":117,"contacts":118},"Equity Medical - Owensboro","NOT_YET_RECRUITING","Owensboro","42303",{"type":96,"coordinates":114},[115,116],-87.11333,37.77422,{"lat":116,"lon":115},[119,124],{"name":120,"role":83,"phone":121,"phoneExt":122,"email":123},"Dr. David Johnsonn","270-426-9184","457","djohnson@equity-med.com",{"name":120,"role":107,"phone":71,"phoneExt":71,"email":71},{"facility":126,"status":89,"city":127,"state":127,"zip":128,"country":93,"countryCode":94,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"Equity Medical LLC","New York","10023",{"type":96,"coordinates":130},[131,132],-74.00597,40.71427,{"lat":132,"lon":131},[135,138],{"name":136,"role":83,"phone":104,"phoneExt":71,"email":137},"Dr. Monalyn Zousias","Mzouzias@equity-med.com",{"name":136,"role":107,"phone":71,"phoneExt":71,"email":71},{"facility":140,"status":89,"city":141,"state":142,"zip":143,"country":144,"countryCode":145,"cosmosGeoPoint":146,"geoPoint":150,"contacts":151},"Linear Clinical Research","Perth","Western Australia","6009","Australia","AU",{"type":96,"coordinates":147},[148,149],115.8614,-31.95224,{"lat":149,"lon":148},[152,154],{"name":153,"role":83,"phone":71,"phoneExt":71,"email":71},"Lara Hatchuel, Dr",{"name":155,"role":107,"phone":71,"phoneExt":71,"email":71},"Dr. Lara Hatchuel",{"facility":157,"status":89,"city":158,"state":71,"zip":159,"country":144,"countryCode":145,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"Momentum Clinical Research","Brisbane","4068",{"type":96,"coordinates":161},[162,163],153.02809,-27.46794,{"lat":163,"lon":162},[166,170],{"name":167,"role":83,"phone":168,"phoneExt":71,"email":169},"Dr Xin Yi (Ellie) Ngoh","0732785255","Ellie.Ngoh@momentumclinicalresearch.com.au",{"name":167,"role":107,"phone":71,"phoneExt":71,"email":71},{"facility":172,"status":89,"city":173,"state":71,"zip":174,"country":175,"countryCode":176,"cosmosGeoPoint":177,"geoPoint":181,"contacts":182},"Aleksandre Aladashvili Clinic LLC","Tbilisi","0198","Georgia","GE",{"type":96,"coordinates":178},[179,180],44.83412,41.69143,{"lat":180,"lon":179},[183,187],{"name":184,"role":83,"phone":185,"phoneExt":71,"email":186},"Dr. Sopiko Kruashvili","+995598530083","Sophiekruashvili@gmail.com",{"name":184,"role":107,"phone":71,"phoneExt":71,"email":71},{"facility":189,"status":89,"city":173,"state":71,"zip":174,"country":175,"countryCode":176,"cosmosGeoPoint":190,"geoPoint":192,"contacts":193},"Geo Hospitals Tbilisi Multiprofile Medical Center",{"type":96,"coordinates":191},[179,180],{"lat":180,"lon":179},[194,198],{"name":195,"role":83,"phone":196,"phoneExt":71,"email":197},"Dr. Elene Khurtsidze","+995574747574","ekhurtsidze@gh.ge",{"name":199,"role":107,"phone":71,"phoneExt":71,"email":71},"Elene Khurtsidze",{"facility":201,"status":89,"city":173,"state":71,"zip":174,"country":175,"countryCode":176,"cosmosGeoPoint":202,"geoPoint":204,"contacts":205},"LEPL The First University Clinic of Tbilisi State Medical University",{"type":96,"coordinates":203},[179,180],{"lat":180,"lon":179},[206,209],{"name":207,"role":83,"phone":71,"phoneExt":71,"email":208},"Dr. Shorena Khazaradze","shorenakhazaradze01@gmail.com",{"name":207,"role":107,"phone":71,"phoneExt":71,"email":71},{"facility":211,"status":89,"city":173,"state":71,"zip":174,"country":175,"countryCode":176,"cosmosGeoPoint":212,"geoPoint":214,"contacts":215},"Ltd Aversi Clinic",{"type":96,"coordinates":213},[179,180],{"lat":180,"lon":179},[216,220],{"name":217,"role":83,"phone":218,"phoneExt":71,"email":219},"Dr. David Tchkonia","+995577785575","David.tchkonia@gmail.com",{"name":221,"role":107,"phone":71,"phoneExt":71,"email":71},"David Tchkonia",{"facility":223,"status":110,"city":224,"state":225,"zip":226,"country":227,"countryCode":228,"cosmosGeoPoint":229,"geoPoint":233,"contacts":234},"Momentum Clinical Research Hamilton","Rotorua","Hamilton","3010","New Zealand","NZ",{"type":96,"coordinates":230},[231,232],176.24516,-38.13874,{"lat":232,"lon":231},[235,239],{"name":236,"role":83,"phone":237,"phoneExt":71,"email":238},"Dr Victoria Siriett","0273415595","Victoria@clinicaltrialswaikato.co.nz",{"name":236,"role":107,"phone":71,"phoneExt":71,"email":71},{"facility":157,"status":89,"city":241,"state":71,"zip":242,"country":227,"countryCode":228,"cosmosGeoPoint":243,"geoPoint":247,"contacts":248},"Pukekohe","2120",{"type":96,"coordinates":244},[245,246],174.90363,-37.20196,{"lat":246,"lon":245},[249,253],{"name":250,"role":83,"phone":251,"phoneExt":71,"email":252},"Dr Michelle Baker","+640508919919","Michelle.baker@momentumclinicalresearch.co.nz",{"name":250,"role":107,"phone":71,"phoneExt":71,"email":71},{"facility":157,"status":89,"city":255,"state":71,"zip":256,"country":227,"countryCode":228,"cosmosGeoPoint":257,"geoPoint":261,"contacts":262},"Wellington","6021",{"type":96,"coordinates":258},[259,260],174.77557,-41.28664,{"lat":260,"lon":259},[263,267],{"name":264,"role":83,"phone":265,"phoneExt":71,"email":266},"Dr Dean Quinn","+6448010002","dean@p3research.co.nz",{"name":264,"role":107,"phone":71,"phoneExt":71,"email":71},{"facility":269,"status":110,"city":270,"state":71,"zip":271,"country":272,"countryCode":273,"cosmosGeoPoint":274,"geoPoint":278,"contacts":279},"Uniwersyteckie Centrum Kliniczne Osrodka Badan Klinicznych Wczesnych Faz","Gdansk","80-214","Poland","PL",{"type":96,"coordinates":275},[276,277],18.64912,54.35227,{"lat":277,"lon":276},[280,284],{"name":281,"role":83,"phone":282,"phoneExt":71,"email":283},"Iwona Damps-Konstanska","+48 535575210","katarzyna.swietnicka@gmail.com",{"name":281,"role":107,"phone":71,"phoneExt":71,"email":71},{"facility":286,"status":110,"city":287,"state":71,"zip":288,"country":272,"countryCode":273,"cosmosGeoPoint":289,"geoPoint":293,"contacts":294},"Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o.o.","Krakow","31-011",{"type":96,"coordinates":290},[291,292],19.93658,50.06143,{"lat":292,"lon":291},[295,299],{"name":296,"role":83,"phone":297,"phoneExt":71,"email":298},"Katarzyna Gajda","48690000367","katarzyna.gajda@dobrylekarz.com.pl",{"name":296,"role":107,"phone":71,"phoneExt":71,"email":71},{"type":301,"investigatorFullName":71,"investigatorTitle":71,"investigatorAffiliation":71,"oldNameTitle":71,"oldOrganization":71},"SPONSOR","100588709","phase-1-a-study-of-bbt002-in-healthy-volunteers-hvs-and-in-adult-patients-with-chronic-obstructive-pulmonary-disease-copd-or-chronic-rhiosininusitis-with-nasal-polyps-crswnp-100588709",false,"NCT06944925","A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)","A Randomized, Double-Blind, Placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT002 in Healthy Volunteers and Patients With COPD or CRSwNP","Key Inclusion Criteria (Parts A, B, C, D, E, F, and G)\n\n1. Age 18-65 years for HVs (Parts A, B, and E); age 35-80 years for patients with COPD (Parts C and F,); age 18-80 for patients with CRSwNP (Parts D and G)\n2. Body mass index between 18.0-32.0 kg\u002Fm square, capped weight at 120kg, for HVs (Parts A, B, and E); body mass index between 16.0-35.0 kg\u002Fm square, capped weight at 125kg for patients (Parts C, D, F, and G)\n3. Negative pregnancy tests for women of childbearing potential\n4. Willingness to refrain from alcohol consumption for 24 hours prior to each study visit\n5. Non-smokers, healthy current smokers (≤5 cigarettes\u002Fday), or ex-smokers\n6. Adequate contraception use (for men and women of childbearing potential)\n7. No clinically significant abnormalities or history of relevant diseases\n\nKey Inclusion Criteria (Part C and F only) 1. Documented history of COPD with a post-bronchodilator Forced Expiratory Volume in 1 second\u002FForced Vital Capacity less than 0.70\n\nKey Inclusion Criteria (Parts D and G)\n\n1\\. Participants with confirmed diagnosis of CRSwNP\n\nKey Exclusion Criteria for (Parts A, B, C, D, E, F, and G)\n\n1. Positive viral serology for human immunodeficiency virus (HlV), hepatitis C virus (HCV), or hepatitis B (HBV)\n2. Immunodeficiencies, autoimmune diseases, or cancer, history of conditions predisposing to infections\n3. History of major metabolic, dermatological, liver, kidney, hematological or other significant disorders\n4. Clinically relevant abnormal lab results, including low blood counts, liver enzymes, or abnormal kidney function\n5. Positive drug\u002Falcohol tests or abnormal vital signs at screening or Day -1\n6. Abnormal Electrocardiogram(ECG) findings\n7. History of drug\u002Falcohol abuse in the past 2 years\n8. History of severe allergic reactions or hypersensitivity\n\nKey Exclusion Criteria (Part C and F only)\n\n1. Current diagnosis of other significant pulmonary disease\n2. Significant or unstable cardiovascular diseases\n3. Recent clinically significant infection\n4. Inability to perform spirometry\n\nKey Exclusion Criteria (Parts D and G)\n\n1. Steroid refractoriness: Refractory to systemic corticosteriods for CRSwNP\n2. Sinonasal surgery (recent\u002Fextensiv)\n3. Consitions interfering with nasal assessments\n4. Excluded sinonasal\u002Fsystemic diseases",true,"ALL","18 Years","80 Years",{"count":314,"type":315},286,"ESTIMATED","INTERVENTIONAL",[318],"PHASE1","Randomized study of single and multiple doses of BBT002 in healthy volunteers and in adult patients with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP).",[321],"Chronic Obstructive Pulmonary Disease","2026-06-28",{"date":324,"type":325},"2026-07-01","ACTUAL",{"date":327,"type":325},"2025-05-08",{"date":329,"type":315},"2027-07-31",{"name":5,"class":6},14]